Spanish Red Biotech Pipeline

Gilead Sciences

Brexucabtagene autoleucel

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Pediatric acute lymphocytic leukemia
Phase: 2Phase II in Spain, 1Phase I in Spain